MYC and head and neck cancer: Silencing c-myc reduced the mRNA level of HK-II in HK1 and FaDu cells, whereas overexpression of c-myc increased the mRNA level of HK-II, indicating that c-myc transcriptionally regulates HK-II in head and neck cancer cell (Fig. S2).